Cutler Investment Counsel LLC Abbott Laboratories Transaction History

Cutler Investment Counsel LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	SELL	$90.19 - $110.4 $270 - $331	-3 Reduced 0.09%	3,385 $372,000
Q3 2023 Oct 25, 2023	BUY	$95.53 - $114.62 $14,711 - $17,651	154 Added 4.76%	3,388 $328,000
Q2 2023 Jul 25, 2023	SELL	$100.78 - $112.29 $19,047 - $21,222	-189 Reduced 5.52%	3,234 $352,000
Q1 2023 May 11, 2023	BUY	$96.86 - $114.01 $6,199 - $7,296	64 Added 1.91%	3,423 $346,000
Q4 2022 Jan 26, 2023	SELL	$95.06 - $111.52 $115,688 - $135,719	-1,217 Reduced 26.6%	3,359 $0
Q3 2022 Nov 07, 2022	BUY	$96.76 - $112.03 $1,644 - $1,904	17 Added 0.37%	4,576 $443,000
Q1 2022 May 10, 2022	BUY	$114.02 - $139.04 $519,817 - $633,883	4,559 New	4,559 $540,000

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Cutler Investment Counsel LLC, based on Form 13F filings with the SEC.

Stay updated on Cutler Investment Counsel LLC with notifications on news.